NDC 54575-465
THYME
Thyme
THYME is a Percutaneous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Allergy Laboratories, Inc.. The primary component is Thyme.
| Product ID | 54575-465_dbe7bebd-e445-4e59-8302-e706b795fbde |
| NDC | 54575-465 |
| Product Type | Human Prescription Drug |
| Proprietary Name | THYME |
| Generic Name | Thyme |
| Dosage Form | Injection, Solution |
| Route of Administration | PERCUTANEOUS; SUBCUTANEOUS |
| Marketing Start Date | 1972-08-29 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102192 |
| Labeler Name | Allergy Laboratories, Inc. |
| Substance Name | THYME |
| Active Ingredient Strength | 1 g/20mL |
| Pharm Classes | Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Dietary Proteins [CS],Food Additives [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
Packaging
NDC 54575-465-10
10 mL in 1 VIAL, MULTI-DOSE (54575-465-10)
| Marketing Start Date | 1972-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 54575-465-02 [54575046502]
THYME INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
NDC 54575-465-30 [54575046530]
THYME INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
NDC 54575-465-10 [54575046510]
THYME INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
NDC 54575-465-50 [54575046550]
THYME INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| THYME | 1 g/20mL |
OpenFDA Data
Pharmacological Class
- Non-Standardized Food Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Dietary Proteins [CS]
- Food Additives [CS]
- Allergens [CS]
NDC Crossover Matching brand name "THYME" or generic name "Thyme"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-1746 | Thyme | Thym |
| 36987-1747 | Thyme | Thym |
| 36987-1748 | Thyme | Thym |
| 36987-1749 | Thyme | Thym |
| 49288-0572 | Thyme | Thyme |
| 54575-465 | THYME | thyme |
| 13838-1447 | Thymus vulgaris (N) | THYME |
Trademark Results [THYME]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 THYME 97908011 not registered Live/Pending |
Glance InMobi Pte. Ltd 2023-04-26 |
 THYME 90351779 not registered Live/Pending |
Goldflower, LLC 2020-12-01 |
 THYME 90183509 not registered Live/Pending |
iHerb Logistics, LLC 2020-09-16 |
 THYME 88884818 not registered Live/Pending |
Chanson 23rd Street LLC 2020-04-23 |
 THYME 87645239 not registered Live/Pending |
Thyme Restaurants, LLC 2017-10-13 |
 THYME 86854765 not registered Dead/Abandoned |
Mark Alan Hemphill 2015-12-19 |
 THYME 86826154 5230348 Live/Registered |
LG ELECTRONICS INC. 2015-11-19 |
 THYME 86638375 5375670 Live/Registered |
Reitmans (Canada) Limited 2015-05-21 |
 THYME 86437475 not registered Dead/Abandoned |
OTG Experience, LLC 2014-10-28 |
 THYME 85967787 not registered Dead/Abandoned |
THYME RESTAURANTS, LLC 2013-06-24 |
 THYME 85838685 4368665 Live/Registered |
Reitmans (Canada) Limited 2013-02-01 |
 THYME 85613679 4261295 Dead/Cancelled |
TartanSoft, LLC 2012-05-01 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.